AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Bergeron, RJ Muller, R McManis, JS Yao, GW Huang, GF
Citation: Rj. Bergeron et al., An improved synthesis of (3S,12S)-N-1,N-14-diethyl-3,12-dihydroxy-homospermine, a polyamine analogue therapeutic agent, SYNTHESIS-S, (7), 2001, pp. 1043-1048

Authors: Bergeron, RJ Wiegand, J McManis, JS Weimar, WR Smith, RE Algee, SE Fannin, TL Slusher, MA Snyder, PS
Citation: Rj. Bergeron et al., Polyamine analogue antidiarrheals: A structure-activity study, J MED CHEM, 44(2), 2001, pp. 232-244

Authors: Bergeron, RJ Muller, R Huang, GF McManis, JS Algee, SE Yao, H Weimar, WR Wiegand, J
Citation: Rj. Bergeron et al., Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives, J MED CHEM, 44(15), 2001, pp. 2451-2459

Authors: Bergeron, RJ Xin, MG Weimar, WR Smith, RE Wiegand, J
Citation: Rj. Bergeron et al., Significance of asymmetric sites in choosing siderophores as deferration agents, J MED CHEM, 44(15), 2001, pp. 2469-2478

Authors: Rao, L Choppin, GR Bergeron, RJ
Citation: L. Rao et al., Complexation of thorium(IV) with desmethyldesferrithiocin, RADIOCH ACT, 88(12), 2000, pp. 851-856

Authors: Bergeron, RJ Muller, R Bussenius, J McManis, JS Merriman, RL Smith, RE Yao, H Weimar, WR
Citation: Rj. Bergeron et al., Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives, J MED CHEM, 43(2), 2000, pp. 224-235

Authors: Bergeron, RJ Merriman, RL Olson, SG Wiegand, J Bender, J Streiff, RR Weimar, WR
Citation: Rj. Bergeron et al., Metabolism and pharmacokinetics of N-1,N-11-diethylnorspermine in a Cebus apella primate model, CANCER RES, 60(16), 2000, pp. 4433-4439

Authors: Bergeron, RJ Bussenius, J Muller, R McCosar, BH McManis, JS
Citation: Rj. Bergeron et al., (R)- and (S)-N-(benzyloxycarbonyl)-3,4-epoxybutylamine. New 4-amino-2-bydroxybutyl synthons for the synthesis of hypusine reagents and (R)-6-and (S)-7-hydroxyspermidine, TETRAHEDR-A, 10(22), 1999, pp. 4285-4294

Authors: Bergeron, RJ Weimar, WR Wiegand, J
Citation: Rj. Bergeron et al., Pharmacokinetics of orally administered desferrithiocinn analogs in Cebus apella primates, DRUG META D, 27(12), 1999, pp. 1496-1498

Authors: Bergeron, RJ McManis, JS Bussenius, J Brittenham, GN Wiegand, J
Citation: Rj. Bergeron et al., Evaluation of the desferrithiocin pharmacophores as a vector for hydroxamates, J MED CHEM, 42(15), 1999, pp. 2881-2886

Authors: Bergeron, RJ Wiegand, J McManis, JS McCosar, BH Weimar, WR Brittenham, GM Smith, RE
Citation: Rj. Bergeron et al., Effects of C-4 stereochemistry and C-4 ' hydroxylation on the iron clearing efficiency and toxicity of desferrithiocin analogues, J MED CHEM, 42(13), 1999, pp. 2432-2440

Authors: Bergeron, RJ Wiegand, J Weimar, WR Vinson, JRT Bussenius, J Yao, GW McManis, JS
Citation: Rj. Bergeron et al., Desazadesmethyldesferrithiocin analogues as orally effective iron chelators, J MED CHEM, 42(1), 1999, pp. 95-108

Authors: Kramer, DL Vujcic, S Diegelman, P Alderfer, J Miller, JT Black, JD Bergeron, RJ Porter, CW
Citation: Dl. Kramer et al., Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G(1)arrest in human melanoma cells, CANCER RES, 59(6), 1999, pp. 1278-1286

Authors: Bergeron, RJ Wiegand, J Brittenham, GM
Citation: Rj. Bergeron et al., HBED: The continuing development of a potential alternative to deferoxamine for iron-chelating therapy, BLOOD, 93(1), 1999, pp. 370-375
Risultati: 1-14 |